138 related articles for article (PubMed ID: 28070166)
1. Biochemical Recurrence Prediction in High-Risk Prostate Cancer Patients, Following Robot-Assisted Radical Prostatectomy.
Yamaguchi N; Yumioka T; Iwamoto H; Masago T; Morizane S; Honda M; Sejima T; Takenaka A
Yonago Acta Med; 2016 Dec; 59(4):288-295. PubMed ID: 28070166
[TBL] [Abstract][Full Text] [Related]
2. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
3. National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence after radical prostatectomy: a retrospective cohort study in Chinese prostate cancer patients.
Xu H; Zhu Y; Dai B; Ye DW
Asian J Androl; 2018; 20(6):551-554. PubMed ID: 30027928
[TBL] [Abstract][Full Text] [Related]
4. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
[TBL] [Abstract][Full Text] [Related]
5. Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot-assisted radical prostatectomy.
Shimodaira K; Inoue R; Hashimoto T; Satake N; Shishido T; Namiki K; Harada K; Nagao T; Ohno Y
Cancer Med; 2024 Mar; 13(5):e7086. PubMed ID: 38477506
[TBL] [Abstract][Full Text] [Related]
6. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
[TBL] [Abstract][Full Text] [Related]
7. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry.
Ong WL; Evans SM; Spelman T; Kearns PA; Murphy DG; Millar JL
BJU Int; 2016 Oct; 118(4):563-9. PubMed ID: 26573954
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients.
Kanehira M; Takata R; Ishii S; Ito A; Ikarashi D; Matsuura T; Kato Y; Obara W
Int J Clin Oncol; 2019 Sep; 24(9):1099-1104. PubMed ID: 30972506
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.
Lughezzani G; Lazzeri M; Buffi NM; Abrate A; Mistretta FA; Hurle R; Pasini L; Castaldo L; Zandegiacomo De Zorzi S; Peschechera R; Fiorini G; Taverna G; Casale P; Guazzoni G
Urol Oncol; 2015 Aug; 33(8):337.e7-14. PubMed ID: 26055430
[TBL] [Abstract][Full Text] [Related]
11. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
[TBL] [Abstract][Full Text] [Related]
12. Prediction of biochemical recurrence after laparoscopic radical prostatectomy.
Bejrananda T; Pliensiri P
BMC Urol; 2023 Nov; 23(1):183. PubMed ID: 37953250
[TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
[TBL] [Abstract][Full Text] [Related]
15. Blood transfusion had no influence on the 5-year biochemical recurrence after robot-assisted radical prostatectomy: a retrospective study.
Han J; Jeon YT; Ryu JH; Oh AY; Kim H; Bae YK; Koo CH
BMC Urol; 2021 Nov; 21(1):160. PubMed ID: 34789219
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of biopsy-derived cell cycle progression score in patients with National Comprehensive Cancer Network low-risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance.
Tosoian JJ; Chappidi MR; Bishoff JT; Freedland SJ; Reid J; Brawer M; Stone S; Schlomm T; Ross AE
BJU Int; 2017 Dec; 120(6):808-814. PubMed ID: 28481440
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.
Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
Eur Urol Focus; 2018 Apr; 4(3):351-359. PubMed ID: 28753802
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Outcomes Following Robot-Assisted Radical Prostatectomy for Clinical T3 Prostate Disease.
Zilberman DE; Abu-Ghanem Y; Raviv G; Rosenzweig B; Fridman E; Portnoy O; Dotan ZA
Isr Med Assoc J; 2021 Feb; 23(2):111-115. PubMed ID: 33595217
[TBL] [Abstract][Full Text] [Related]
19. Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer.
Yang CK; Yang CR; Ou YC; Cheng CL; Ho HC; Chiu KY; Wang SS; Li JR; Chen CS; Hung CF; Chen CC; Wang SC; Lin CY; Hung SC
Oncol Lett; 2023 Jul; 26(1):284. PubMed ID: 37274483
[TBL] [Abstract][Full Text] [Related]
20. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]